We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bank of N.T. Butterfield & Son
NTB
$2.33B
| $6.11M | 0.01% |
137,993
+75,668
| +121% | +$3.1M |
|
677
Redwire
RDW
$2.82B
| $6.11M | 0.01% |
374,739
-123,407
| -25% | -$1.61M |
|
678
US Foods
USFD
$23.3B
| $6.1M | 0.01% |
79,178
-12,010
| -13% | -$857K |
|
679
Griffon
GFF
$4.49B
| $6.1M | 0.01% |
84,228
-16,451
| -16% | -$1.15M |
|
680
STAAR Surgical
STAA
$1.12B
| $6.1M | 0.01% |
+363,233
| New | +$6.4M |
|
681
Neogen
NEOG
$2.56B
| $6.04M | 0.01% |
+1,263,289
| New | +$7.25M |
|
682
First Financial Bankshares
FFIN
$4.74B
| $5.99M | 0.01% |
166,554
-3,925
| -2% | -$136K |
|
683
Robinhood
HOOD
$98.7B
| $5.99M | 0.01% |
63,957
+32,933
| +106% | +$1.95M |
|
684
Stanley Black & Decker
SWK
$15B
| $5.98M | 0.01% |
88,277
+40,449
| +85% | +$2.61M |
|
685
Commercial Metals
CMC
$7.61B
| $5.97M | 0.01% |
122,106
-21,484
| -15% | -$995K |
|
686
Myriad Genetics
MYGN
$304M
| $5.96M | 0.01% |
1,122,333
+1,121,254
| +103,916% | +$6.62M |
|
687
TechnipFMC
FTI
$29.9B
| $5.94M | 0.01% |
172,551
-11,356
| -6% | -$343K |
|
|
EFOR
688
Everforth Inc
EFOR
$1.3B
| $5.92M | 0.01% |
118,613
+114,418
| +2,727% | +$6.25M |
|
689
Axsome Therapeutics
AXSM
$10.8B
| $5.89M | 0.01% |
56,469
+30,479
| +117% | +$3.23M |
|
690
American Water Works
AWK
$27.2B
| $5.89M | 0.01% |
42,353
-4,300
| -9% | -$616K |
|
691
Krystal Biotech
KRYS
$10.6B
| $5.88M | 0.01% |
42,743
+29,962
| +234% | +$4.4M |
|
692
HP
HPQ
$27.1B
| $5.86M | 0.01% |
239,517
-242,579
| -50% | -$6.18M |
|
693
LivaNova
LIVN
$4.41B
| $5.85M | 0.01% |
129,866
-14,250
| -10% | -$588K |
|
694
AXIS Capital
AXS
$7.23B
| $5.84M | 0.01% |
56,212
+811
| +1% | +$80.7K |
|
|
JHG
695
DELISTED
Janus Henderson
JHG
| $5.82M | 0.01% |
149,822
+4,256
| +3% | +$150K |
|
696
Seadrill
SDRL
$3.03B
| $5.8M | 0.01% |
221,040
+220,984
| +394,614% | +$5.22M |
|
697
Jacobs Solutions
J
$17.6B
| $5.8M | 0.01% |
44,097
-457
| -1% | -$56.3K |
|
698
Pitney Bowes
PBI
$2.37B
| $5.73M | 0.01% |
525,512
+7,292
| +1% | +$68.6K |
|
699
DTE Energy
DTE
$28.3B
| $5.72M | 0.01% |
43,192
+935
| +2% | +$126K |
|
700
VF Corp
VFC
$5.36B
| $5.66M | 0.01% |
481,910
+397,097
| +468% | +$4.92M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.